HOLLISTON, Mass., Aug. 13, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat life-thre

ST. LOUIS, Aug. 13, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that it is expanding its offerings in the 2020 Health Insurance Marketplace, or exchange. The company is expanding its footprint in ten markets: Arizona, Florida, Georgia

- FDA agrees to allow initiation of NODE-303 open-label safety study without test dose and in population consistent with ongoing studies -- NODE-301 trial upsized from 100 to 150 adjudicated PSVT events to satisfy EMA requirements; Company remains on track for topline readout in 1H20 -- Company to host mid-year business update conference call today at 8:00 a.m. ET -

BRENTWOOD, Tenn., Aug. 13, 2019 /PRNewswire/ -- Brookdale Senior Living, the nation's leading operator of senior living communities, is pleased to announce the launch of its newly redesigned newsroom,

MAPLE GROVE, Minn., Aug. 13, 2019 /PRNewswire/ -- Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, announced today that the latest edition of NephSAP® featured the company's ClearGuard HD Antimicrobial Barrier Caps as a key component of a global strategy to reduce bloodstream infections in hemodialysis patients. 

SOMERDALE, N.J., Aug. 13, 2019 /PRNewswire/ -- The aftermath of the deluge of prescription pain pills that flooded New Jersey and other states in the last decade continues to cause an increased need for addiction treatment services for opioid dependency. To meet that need, Recovery Centers of America ("RCA") today opened a second opioid t

INDIANAPOLIS, Aug. 13, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today Taltz® (ixekizumab) met the primary and all major secondary endpoints up to week 12 in the Phase 4 IXORA-R study, which evaluated the efficacy and safety of Taltz versus TREMFYA® (guselkumab) in people living with moderate to severe plaque psor

BOSTON, Aug. 13, 2019 /PRNewswire/ -- Seven Bridges, the industry-leading bioinformatics solution provider, today announced plans to expand operations into Novi Sad, Serbia in support of their growing customer base and to expedite product innovation.

NEW YORK and CAESAREA, Israel, Aug. 13, 2019 /PRNewswire/ -- Q2 2019 Revenue of $1.65 million, a 20% decline from Q2 2018 Record 1H 2019 Revenue of $3.89 million, a 2% increase over 1H 2018 Expense shift from D2C to

BALTIMORE, Aug. 13, 2019 /PRNewswire/ -- New research, published today in the flagship journal of the American Society for Microbiology, is the first to identify a specific mechanism by which keystone species of bacteria in the vaginal microbiome affect a woman's susceptibility to sexually transmitted infections.The research is timely amidst a rising number of sex